Mallinckrodt's extended-release pain drug meets main goal of study

(Reuters) - Specialty pharmaceutical company Mallinckrodt Plc said its experimental painkiller significantly reduced the intensity of pain in patients who had undergone a surgical removal of bunions.

via Reuters: Health News Read More Here..